165 related articles for article (PubMed ID: 22187037)
1. Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysis.
Cardinale F; Bruzzi P; Bolognesi C
Br J Cancer; 2012 Feb; 106(4):780-90. PubMed ID: 22187037
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
Speit G; Trenz K
Cytogenet Genome Res; 2004; 104(1-4):325-32. PubMed ID: 15162060
[TBL] [Abstract][Full Text] [Related]
3. Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers.
Gutiérrez-Enríquez S; Ramón Y Cajal T; Alonso C; Corral A; Carrasco P; Cornet M; Sanz J; Ribas M; Baiget M; Diez O
Breast Cancer Res Treat; 2011 Jun; 127(3):611-22. PubMed ID: 20625817
[TBL] [Abstract][Full Text] [Related]
4. Micronuclei and upper body cancers (head, neck, breast cancers) a systematic review and meta-analysis.
Bolognesi C; Bruzzone M; Ceppi M; Marcon F
Mutat Res Rev Mutat Res; 2021; 787():108358. PubMed ID: 34083052
[TBL] [Abstract][Full Text] [Related]
5. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families.
Rothfuss A; Schütz P; Bochum S; Volm T; Eberhardt E; Kreienberg R; Vogel W; Speit G
Cancer Res; 2000 Jan; 60(2):390-4. PubMed ID: 10667592
[TBL] [Abstract][Full Text] [Related]
6. Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation.
Trenz K; Rothfuss A; Schütz P; Speit G
Mutat Res; 2002 Mar; 500(1-2):89-96. PubMed ID: 11890937
[TBL] [Abstract][Full Text] [Related]
7. BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis.
Zhu Y; Wu J; Zhang C; Sun S; Zhang J; Liu W; Huang J; Zhang Z
Oncotarget; 2016 Oct; 7(43):70113-70127. PubMed ID: 27659521
[TBL] [Abstract][Full Text] [Related]
8. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer.
Stadler ZK; Salo-Mullen E; Patil SM; Pietanza MC; Vijai J; Saloustros E; Hansen NA; Kauff ND; Kurtz RC; Kelsen DP; Offit K; Robson ME
Cancer; 2012 Jan; 118(2):493-9. PubMed ID: 21598239
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers.
Baeyens A; Thierens H; Claes K; Poppe B; de Ridder L; Vral A
Int J Radiat Biol; 2004 Oct; 80(10):745-56. PubMed ID: 15799620
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of micronucleus test: a case-control study on the prediction of breast cancer risk/susceptibility.
Bolognesi C; Bruzzi P; Gismondi V; Volpi S; Viassolo V; Pedemonte S; Varesco L
PLoS One; 2014; 9(11):e112354. PubMed ID: 25415331
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.
Beetstra S; Salisbury C; Turner J; Altree M; McKinnon R; Suthers G; Fenech M
Carcinogenesis; 2006 Mar; 27(3):517-24. PubMed ID: 16162645
[TBL] [Abstract][Full Text] [Related]
13. [The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic].
Pohlreich P; Kleibl Z; Kleiblová P; Janatová M; Soukupová J; Macháčková E; Házová J; Vašíčková P; Sťahlová Hrabincová E; Navrátilová M; Svoboda M; Foretová L
Klin Onkol; 2012; 25 Suppl():S59-66. PubMed ID: 22920209
[TBL] [Abstract][Full Text] [Related]
14. On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls.
Varga D; Hoegel J; Maier C; Jainta S; Hoehne M; Patino-Garcia B; Michel I; Schwarz-Boeger U; Kiechle M; Kreienberg R; Vogel W
Mutagenesis; 2006 Sep; 21(5):313-20. PubMed ID: 16928695
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer risk.
Teixeira N; Mourits MJ; Vos JR; Kolk DM; Jansen L; Oosterwijk JC; Bock GH
Maturitas; 2015 Oct; 82(2):197-202. PubMed ID: 26239500
[TBL] [Abstract][Full Text] [Related]
16. Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
Sokolenko AP; Sokolova TN; Ni VI; Preobrazhenskaya EV; Iyevleva AG; Aleksakhina SN; Romanko AA; Bessonov AA; Gorodnova TV; Anisimova EI; Savonevich EL; Bizin IV; Stepanov IA; Krivorotko PV; Berlev IV; Belyaev AM; Togo AV; Imyanitov EN
Breast Cancer Res Treat; 2020 Nov; 184(1):229-235. PubMed ID: 32776218
[TBL] [Abstract][Full Text] [Related]
17. Thyroid Hormones and Vitamin D in Patients with Breast Cancer with Mutations in BRCA1 or BRCA2 Genes.
Kolben T; Hary T; Holdt LM; Schwarz TM; Goess C; Wuerstlein R; Gallwas J; Toth B; Weissenbacher T; Jeschke U; Harbeck N; Ditsch N
Anticancer Res; 2016 Jun; 36(6):3185-90. PubMed ID: 27272846
[TBL] [Abstract][Full Text] [Related]
18. Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.
Pavanello S; Varesco L; Gismondi V; Bruzzi P; Bolognesi C
PLoS One; 2018; 13(5):e0197522. PubMed ID: 29782524
[TBL] [Abstract][Full Text] [Related]
19. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.
Kirova YM; Stoppa-Lyonnet D; Savignoni A; Sigal-Zafrani B; Fabre N; Fourquet A;
Eur J Cancer; 2005 Oct; 41(15):2304-11. PubMed ID: 16140006
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study.
Han SA; Kim SW; Kang E; Park SK; Ahn SH; Lee MH; Nam SJ; Han W; Bae YT; Kim HA; Cho YU; Chang MC; Paik NS; Hwang KT; Kim SJ; Noh DY; Choi DH; Noh WC; Kim LS; Kim KS; Suh YJ; Lee JE; Jung Y; Moon BI; Yang JH; Son BH; Yom CK; Kim SY; Lee H; Jung SH;
Fam Cancer; 2013 Mar; 12(1):75-81. PubMed ID: 23131904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]